Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Hao LiChenxing ZhuJiapei WuYuchen MaXi JinXin WeiKunjie WangHong LiPublished in: International urology and nephrology (2020)
Testicular nonseminoma survivors showed higher risks of kidney and bladder cancer associated with chemotherapy and decreased risk of prostate cancer. The prognosis of urological second neoplasms was better than other tumor origins.